Triple
T32170123
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Hemlibra |
E821686
|
entity |
| Predicate | hasFDALabelIndication |
P23161
|
FINISHED |
| Object | routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors | Statement: [Hemlibra, hasFDALabelIndication, routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasFDALabelIndication Context triple: [Hemlibra, hasFDALabelIndication, routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors]
-
A.
hasUSFDADesignation
Indicates that an entity has been granted a specific formal designation or status by the U.S. Food and Drug Administration (FDA).
-
B.
hasIndication
chosen
Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
-
C.
hasRegulatoryApproval
Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
-
D.
FDAApprovalType
Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
-
E.
safetyLabel
Indicates that an entity has been assigned a safety-related classification or warning status.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3490699a48190bbef96b198e8fade |
completed | April 30, 2026, 12:20 p.m. |
| NER | Named-entity recognition | batch_69f6ba73aa9c819082328ddf6ec799ec |
completed | May 3, 2026, 3:01 a.m. |
| PD | Predicate disambiguation | batch_69f6b3a970b0819090c6473844ffa8e3 |
completed | May 3, 2026, 2:32 a.m. |
Created at: May 1, 2026, 12:33 a.m.